Skip to main content
Trial halted for bleeding reduction with abelacimab vs. rivaroxaban in AFib
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Trial halted for bleeding reduction with abelacimab vs. rivaroxaban in AFib
User login
Username
Password
Reset your password
Concept
Lead
score
Atrial Fibrillation
1
1
Thromboembolism
0
0.94
Hemorrhage
0
0.73
Anticoagulation Therapy
0
0.7
Cerebrovascular Accident
0
0.64
Embolism
0
0.21
Thrombus
0
0.15
Blood
0
0.1
Europe
0
0.1
Factor XI Deficiency
0
0.1
Genetics
0
0.1
Grant
0
0.1
Hospital
0
0.1
Ischemic Stroke
0
0.1
Monoclonal Antibody
0
0.1
Surgery
0
0.1
Venous Thromboembolism (VTE)
0
0.1
Biologic Therapy
0
0.08
Genomic Medicine
0
0.08
Hemophilia
0
0.08
Specialty
Lead
score
Cardiology
1
1
Pharmacist
0
0.9
Edit Tags